Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$370M |
| 2 |
Amazon
AMZN
|
+$349M |
| 3 |
Microsoft
MSFT
|
+$336M |
| 4 |
Meta Platforms (Facebook)
META
|
+$181M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.07B |
| 2 |
Newmont
NEM
|
+$149M |
| 3 |
Waste Management
WM
|
+$122M |
| 4 |
McDonald's
MCD
|
+$113M |
| 5 |
Eli Lilly
LLY
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.15% |
| 2 | Healthcare | 14.17% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Communication Services | 11.59% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Mesa Laboratories
MLAB
$633M
| $3.06M | ﹤0.01% |
11,302
+200
| +2% | +$50.7K |
|
|
AMWD
1827
DELISTED
American Woodmark
AMWD
| $3.06M | ﹤0.01% |
37,500
+600
| +2% | +$56.1K |
|
1828
XPEL
XPEL
$1.39B
| $3.06M | ﹤0.01% |
36,500
+1,800
| +5% | +$133K |
|
1829
Extreme Networks
EXTR
$3.16B
| $3.05M | ﹤0.01% |
272,900
-8,200
| -3% | -$87K |
|
1830
Addus HomeCare
ADUS
$2.2B
| $3.04M | ﹤0.01% |
34,800
+500
| +1% | +$48.6K |
|
1831
Enterprise Financial Services Corp
EFSC
$2.4B
| $3.03M | ﹤0.01% |
65,364
-2,400
| -4% | -$118K |
|
|
PGTI
1832
DELISTED
PGT, Inc.
PGTI
| $3.02M | ﹤0.01% |
130,000
-4,800
| -4% | -$119K |
|
1833
James River Group Holdings
JRVR
$200M
| $3M | ﹤0.01% |
79,899
+9,900
| +14% | +$396K |
|
1834
Axcelis
ACLS
$4.42B
| $3M | ﹤0.01% |
74,100
-2,500
| -3% | -$104K |
|
1835
GoPro
GPRO
$117M
| $2.99M | ﹤0.01% |
256,800
-7,700
| -3% | -$86.9K |
|
1836
Cal-Maine
CALM
$3.87B
| $2.98M | ﹤0.01% |
82,400
-3,000
| -4% | -$112K |
|
|
RWT
1837
Redwood Trust
RWT
$599M
| $2.98M | ﹤0.01% |
247,100
-8,600
| -3% | -$95.9K |
|
1838
First Commonwealth Financial
FCF
$2.19B
| $2.98M | ﹤0.01% |
211,900
-7,700
| -4% | -$113K |
|
1839
Astec Industries
ASTE
$975M
| $2.98M | ﹤0.01% |
47,300
+800
| +2% | +$55.8K |
|
1840
Heron Therapeutics
HRTX
$63.5M
| $2.97M | ﹤0.01% |
191,400
-5,800
| -3% | -$92.3K |
|
1841
Fulgent Genetics
FLGT
$513M
| $2.96M | ﹤0.01% |
32,100
+1,600
| +5% | +$128K |
|
|
OCFT
1842
DELISTED
OneConnect Financial Technology
OCFT
| $2.95M | ﹤0.01% |
+24,562
| New | +$3.52M |
|
1843
Columbus McKinnon
CMCO
$550M
| $2.95M | ﹤0.01% |
61,111
+6,500
| +12% | +$333K |
|
1844
Stride
LRN
$3.48B
| $2.94M | ﹤0.01% |
91,600
-3,300
| -3% | -$98.4K |
|
1845
Utz Brands
UTZ
$1.25B
| $2.94M | ﹤0.01% |
134,900
+33,100
| +33% | +$826K |
|
|
SWI
1846
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.94M | ﹤0.01% |
164,857
+28,819
| +21% | +$521K |
|
|
BRMK
1847
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $2.93M | ﹤0.01% |
276,900
-10,100
| -4% | -$107K |
|
1848
Aurinia Pharmaceuticals
AUPH
$2.02B
| $2.93M | ﹤0.01% |
225,500
-20,400
| -8% | -$260K |
|
|
ALEX
1849
DELISTED
Alexander & Baldwin
ALEX
| $2.92M | ﹤0.01% |
159,620
+2,600
| +2% | +$47.9K |
|
1850
Celldex Therapeutics
CLDX
$3.35B
| $2.92M | ﹤0.01% |
87,200
-3,200
| -4% | -$87.8K |
|
Similar funds
Swiss National Bank's Q2 2021 Portfolio in Review
As of Q2 2021, Swiss National Bank held 2,687 positions worth $162B, up 8.1% from $150B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Swiss National Bank's Q2 2021 filing shows 205 new, 908 increased, 1,482 reduced and 45 closed positions. Its largest new stake was Lyft: 1,044,300 shares worth $63.2M. The largest sale was Alibaba, an estimated $1.07B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2021 buy was Lyft: 1,044,300 shares worth $63.2M.
- Swiss National Bank added most to Apple in Q2 2021, an estimated $370M increase.
- Swiss National Bank's biggest Q2 2021 reduction was Newmont, cutting an estimated $149M.
- Swiss National Bank fully exited Alibaba in Q2 2021, selling an estimated $1.07B.
- Swiss National Bank's ten largest holdings make up 25% of its $162B portfolio in Q2 2021.
- Swiss National Bank opened 205 new positions and closed 45 in Q2 2021.
- Swiss National Bank's portfolio value rose 8.1% quarter-over-quarter to $162B.
Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.